PPARγ modulates inflammation through its expression in macrophages and other immune cells. It inhibits the production of pro-inflammatory cytokines and promotes the expression of anti-inflammatory genes. This anti-inflammatory effect is beneficial in conditions such as atherosclerosis and inflammatory bowel disease, where chronic inflammation plays a key role.
